Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Operations (2022 - 2025)

Gossamer Bio's Cash from Operations history spans 4 years, with the latest figure at 48314000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 36.17% year-over-year to 48314000.0; the TTM value through Dec 2025 reached 171266000.0, down 4838.47%, while the annual FY2025 figure was 171266000.0, 4838.47% down from the prior year.
  • Cash from Operations reached 48314000.0 in Q4 2025 per GOSS's latest filing, down from 36167000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 116348000.0 in Q2 2024 to a low of 53483000.0 in Q1 2022.
  • Average Cash from Operations over 4 years is 32557750.0, with a median of 38987500.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: skyrocketed 404.17% in 2024, then crashed 140.45% in 2025.
  • A 4-year view of Cash from Operations shows it stood at 47730000.0 in 2022, then increased by 29.97% to 33424000.0 in 2023, then dropped by 6.15% to 35481000.0 in 2024, then tumbled by 36.17% to 48314000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Cash from Operations are 48314000.0 (Q4 2025), 36167000.0 (Q3 2025), and 47061000.0 (Q2 2025).